Search
for
Sort by
Research 30 of 1000+
- Onset of frontal fibrosing alopecia during inhibition of Th1/17 Pathways with ustekinumab
- Inheritance-Specific Dysregulation of Th1- and Th17-Associated Cytokines in Alopecia Areata
- Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Hair follicles as immune targets: unraveling cellular players, cytokine crosstalk, and precision pathways for future therapy of alopecia areata
- Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab
- Response to ustekinumab in three pediatric patients with alopecia areata
- Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation
- Meta-Analysis of Gene Expression Reveals the Core Transcriptomic Profile of Lesional Scalp in Alopecia Areata
- P100 Critically appraised topic: is dupilumab a cause or a treatment for alopecia areata? A case series and literature review to guide discussions in clinical practice
- BI02 (P97): Epidermal growth factor receptor inhibitor therapy induces a distinct inflammatory hair follicle response that includes a collapse of immune privilege
- Dupilumab: Friend or Foe to Alopecia Areata?
- A case of dupilumab-induced psoriatic alopecia
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- SIRT1 downregulation provokes immune-inflammatory responses in hair follicle outer root sheath cells and may contribute to development of alopecia areata
- Pathogenesis of paradoxical alopecia areata during dupilumab therapy: What is known and unknown
- Dupilumab Associated Progression of Alopecia Areata to Alopecia Universalis: A Case Report
- Epidermal Wnt/beta-catenin signalling promotes dermal adipocyte differentiation during hair follicle morphogenesis and regeneration
- Table 2_A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle.docx
- Image 1_A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle.png
- Table 1_A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle.docx
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Alopecia Areata Associated with Dupilumab: National Database Study
- Successful Treatment of Coexisting Alopecia Areata and Bullous Pemphigoid With Dupilumab: A Case Report
- Alopecia Areata Associated with Dupilumab: A Case Report and Literature Review
- Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)